Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans

This study examines PCSK9i cost-sharing requirements for Medicare Part D plans nationwide, which insure 41 million beneficiaries.

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Cardiol
Autores principales: Kazi, Dhruv S., Lu, Christine Y., Lin, Grace A., DeJong, Colette, Dudley, R. Adams, Chen, Randi, Tseng, Chien-Wen
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2017
Materias:
Research Letter
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815006/
https://ncbi.nlm.nih.gov/pubmed/28903137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2017.3051
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares